OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease
Jingyi Ma, Virender Kumar, Ram I. Mahato
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1894-1894
Open Access | Times Cited: 9
Jingyi Ma, Virender Kumar, Ram I. Mahato
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1894-1894
Open Access | Times Cited: 9
Showing 9 citing articles:
Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice
Virender Kumar, Bharti Sethi, Dalton W. Staller, et al.
Biomaterials (2023) Vol. 295, pp. 122049-122049
Open Access | Times Cited: 11
Virender Kumar, Bharti Sethi, Dalton W. Staller, et al.
Biomaterials (2023) Vol. 295, pp. 122049-122049
Open Access | Times Cited: 11
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access
Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
Noureen Zahra, Shazia Rafique, Zoya Naveed, et al.
Life Sciences (2024) Vol. 345, pp. 122565-122565
Closed Access | Times Cited: 2
Noureen Zahra, Shazia Rafique, Zoya Naveed, et al.
Life Sciences (2024) Vol. 345, pp. 122565-122565
Closed Access | Times Cited: 2
A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases
Dalton W. Staller, Sanjali S. Panigrahi, Yahani P. Jayasinghe, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Dalton W. Staller, Sanjali S. Panigrahi, Yahani P. Jayasinghe, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury
Dalton W. Staller, Robert G. Bennett, Ram I. Mahato
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 7, pp. 545-573
Closed Access | Times Cited: 1
Dalton W. Staller, Robert G. Bennett, Ram I. Mahato
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 7, pp. 545-573
Closed Access | Times Cited: 1
Past, Present, and Future Therapies for Alcohol-associated Hepatitis
Sally Condon, Loretta Jophlin
Clinical Therapeutics (2023) Vol. 45, Iss. 12, pp. 1171-1176
Open Access | Times Cited: 3
Sally Condon, Loretta Jophlin
Clinical Therapeutics (2023) Vol. 45, Iss. 12, pp. 1171-1176
Open Access | Times Cited: 3
Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment
Jingyi Ma, Dalton W. Staler, Ram I. Mahato
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1339-1353
Closed Access
Jingyi Ma, Dalton W. Staler, Ram I. Mahato
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1339-1353
Closed Access
Apremilast Treatment of Cancer in Mice Tumorised with Breast Cancer: In Vivo Study
Abd Zair, Rahi Zainab
Journal of Population Therapeutics and Clinical Pharmacology (2023) Vol. 30, Iss. 7
Open Access
Abd Zair, Rahi Zainab
Journal of Population Therapeutics and Clinical Pharmacology (2023) Vol. 30, Iss. 7
Open Access
Curcumin delivery nanoparticles based on Maillard reaction of Haematococcus pluvialis protein/galactose for alleviating acute alcoholic liver damage
Xinyi Liu, Yukun Song, Shasha Cheng, et al.
Deleted Journal (2023) Vol. 13, Iss. 5, pp. 2629-2641
Open Access
Xinyi Liu, Yukun Song, Shasha Cheng, et al.
Deleted Journal (2023) Vol. 13, Iss. 5, pp. 2629-2641
Open Access
